Clinical outcome and prognostic survival factors in patients with advanced renal cell carcinoma treated with very low-dose interleukin-2, interferon-α, and tegafur-uracil: a single-institution experience

✍ Scribed by Minoru Kobayashi; Hitoshi Ikeda; Akinori Nukui; Kazumi Suzuki; Yasuhiro Sugaya; Masayuki Yuzawa; Tatsuo Morita

• Publisher: Springer
• Year: 2008
• Tongue: English
• Weight: 336 KB
• Volume: 13
• Category: Article
• ISSN: 1341-9625
• DOI: 10.1007/s10147-007-0752-0